Display options
Share it on

Pharmaceutics. 2021 Apr 02;13(4). doi: 10.3390/pharmaceutics13040481.

Peptide-Based Strategies for Targeted Tumor Treatment and Imaging.

Pharmaceutics

Abiodun Ayo, Pirjo Laakkonen

Affiliations

  1. Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
  2. Laboratory Animal Center, HiLIFE-Helsinki Institute of Life Science, University of Helsinki, 00014 Helsinki, Finland.

PMID: 33918106 PMCID: PMC8065807 DOI: 10.3390/pharmaceutics13040481

Abstract

Cancer is one of the leading causes of death worldwide. The development of cancer-specific diagnostic agents and anticancer toxins would improve patient survival. The current and standard types of medical care for cancer patients, including surgery, radiotherapy, and chemotherapy, are not able to treat all cancers. A new treatment strategy utilizing tumor targeting peptides to selectively deliver drugs or applicable active agents to solid tumors is becoming a promising approach. In this review, we discuss the different tumor-homing peptides discovered through combinatorial library screening, as well as native active peptides. The different structure-function relationship data that have been used to improve the peptide's activity and conjugation strategies are highlighted.

Keywords: drug delivery; targeted delivery; tumor homing peptides

References

  1. Transl Lung Cancer Res. 2020 Aug;9(4):1324-1332 - PubMed
  2. PLoS Comput Biol. 2017 Apr 20;13(4):e1005499 - PubMed
  3. Neurosurgery. 2008 Feb;62(2):493-503; discussion 503-4 - PubMed
  4. Cancer Biother Radiopharm. 2017 Feb;32(1):24-32 - PubMed
  5. Chembiochem. 2016 Apr 1;17(7):570-5 - PubMed
  6. Cancer Lett. 2017 Mar 1;388:292-302 - PubMed
  7. Br J Pharmacol. 2008 Sep;155(2):185-97 - PubMed
  8. Bioorg Chem. 2020 Sep;102:104100 - PubMed
  9. Nat Biotechnol. 2000 Nov;18(11):1185-90 - PubMed
  10. Asian Pac J Cancer Prev. 2014;15(3):1145-8 - PubMed
  11. Annu Rev Anal Chem (Palo Alto Calif). 2020 Jun 12;13(1):223-247 - PubMed
  12. J Cell Biol. 1986 Dec;103(6 Pt 2):2637-47 - PubMed
  13. Front Oncol. 2013 Aug 27;3:216 - PubMed
  14. Br J Cancer. 2011 Nov 22;105(11):1697-707 - PubMed
  15. Curr Med Chem. 2017;24(17):1797-1826 - PubMed
  16. Eur J Biochem. 2001 Apr;268(7):2004-12 - PubMed
  17. Biochemistry (Mosc). 2013 Nov;78(11):1228-37 - PubMed
  18. Clin Cancer Res. 2020 Jun 15;26(12):2789-2799 - PubMed
  19. Neuro Oncol. 2015 May;17(5):708-17 - PubMed
  20. Anticancer Res. 2005 Jan-Feb;25(1A):33-42 - PubMed
  21. J Med Chem. 2008 Dec 25;51(24):7980-90 - PubMed
  22. J Biol Chem. 2002 Dec 6;277(49):47891-7 - PubMed
  23. ACS Appl Mater Interfaces. 2017 Feb 22;9(7):5864-5873 - PubMed
  24. Anal Biochem. 2014 Oct 1;462:35-43 - PubMed
  25. J Clin Oncol. 2008 Dec 1;26(34):5610-7 - PubMed
  26. Breast Cancer Res Treat. 2016 Nov;160(1):51-59 - PubMed
  27. J Nucl Med. 2005 Oct;46(10):1707-18 - PubMed
  28. J Control Release. 2019 Aug 10;307:247-260 - PubMed
  29. Biochim Biophys Acta. 1969 Nov 11;194(1):25-33 - PubMed
  30. J Control Release. 2015 Jul 10;209:327-36 - PubMed
  31. J Biol Chem. 2010 Mar 19;285(12):9114-23 - PubMed
  32. J Clin Oncol. 2010 Jun 1;28(16):2712-8 - PubMed
  33. Science. 2010 May 21;328(5981):1031-5 - PubMed
  34. Mol Imaging Biol. 2009 Nov-Dec;11(6):424-33 - PubMed
  35. Proc Natl Acad Sci U S A. 1980 Oct;77(10):5754-8 - PubMed
  36. J Neurooncol. 2014 Mar;117(1):141-5 - PubMed
  37. Clin Genitourin Cancer. 2006 Mar;4(4):299-302 - PubMed
  38. J Nucl Med. 2007 Sep;48(9):1536-44 - PubMed
  39. Ann N Y Acad Sci. 2003 Jun;994:378-83 - PubMed
  40. Proc Natl Acad Sci U S A. 1984 Oct;81(19):5985-8 - PubMed
  41. Biopolymers. 2011;96(2):181-8 - PubMed
  42. FASEB J. 2005 Dec;19(14):1978-85 - PubMed
  43. Endocrinology. 1968 Oct;83(4):783-90 - PubMed
  44. Cancer Res. 2001 Nov 15;61(22):8058-61 - PubMed
  45. Cancer Res. 2006 Apr 1;66(7):3764-72 - PubMed
  46. Eur J Biochem. 2003 Jul;270(14):3055-63 - PubMed
  47. Handb Clin Neurol. 2016;134:381-97 - PubMed
  48. Biomaterials. 2020 Feb;230:119666 - PubMed
  49. J Biomol Struct Dyn. 2018 Apr;36(5):1134-1144 - PubMed
  50. Peptides. 2006 Feb;27(2):388-94 - PubMed
  51. Bioconjug Chem. 2004 Jan-Feb;15(1):41-9 - PubMed
  52. ACS Biomater Sci Eng. 2020 Nov 9;6(11):6207-6216 - PubMed
  53. J Biol Chem. 1996 Sep 20;271(38):23222-9 - PubMed
  54. Biochim Biophys Acta. 1987 Jan 13;917(1):148-61 - PubMed
  55. J Cell Biol. 1994 Feb;124(3):373-80 - PubMed
  56. Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12079-84 - PubMed
  57. Cancer Res. 2004 Feb 15;64(4):1411-8 - PubMed
  58. J Cell Biol. 1997 Aug 25;138(4):877-89 - PubMed
  59. Adv Mater. 2020 Jun;32(24):e2000416 - PubMed
  60. Int J Nanomedicine. 2014 Feb 12;9:921-35 - PubMed
  61. Clin Lung Cancer. 2018 May;19(3):e277-e285 - PubMed
  62. Amino Acids. 2018 Oct;50(10):1415-1431 - PubMed
  63. Nat Commun. 2020 Nov 10;11(1):5696 - PubMed
  64. Eur J Biochem. 1992 Dec 15;210(3):911-21 - PubMed
  65. Nat Rev Cancer. 2002 Feb;2(2):83-90 - PubMed
  66. Nat Cancer. 2021 Feb;2(2):141-156 - PubMed
  67. Bioconjug Chem. 2014 Feb 19;25(2):231-9 - PubMed
  68. J Cell Biol. 1984 Jul;99(1 Pt 1):29-36 - PubMed
  69. Life Sci. 1982 Sep 13;31(11):1133-40 - PubMed
  70. Mol Cancer Ther. 2006 Aug;5(8):1944-9 - PubMed
  71. Bioconjug Chem. 2004 Jan-Feb;15(1):61-9 - PubMed
  72. Br J Cancer. 2004 Feb 9;90(3):561-5 - PubMed
  73. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8057-61 - PubMed
  74. Cancer Lett. 2017 Aug 28;402:16-31 - PubMed
  75. Acta Histochem Cytochem. 2012 Jun 28;45(3):167-76 - PubMed
  76. Cancer Chemother Pharmacol. 2017 Jun;79(6):1221-1227 - PubMed
  77. Br J Dermatol. 2015 Jun;172(6):1601-1612 - PubMed
  78. Nat Biotechnol. 1999 Aug;17(8):768-74 - PubMed
  79. J Nucl Med. 2006 Jan;47(1):113-21 - PubMed
  80. EMBO J. 1985 Oct;4(10):2519-24 - PubMed
  81. Pharmaceutics. 2019 May 07;11(5): - PubMed
  82. Methods Enzymol. 2012;503:35-56 - PubMed
  83. J Cell Biol. 1989 Mar;108(3):1149-55 - PubMed
  84. J Clin Invest. 2002 Aug;110(4):475-82 - PubMed
  85. Methods Mol Biol. 2011;683:401-15 - PubMed
  86. J Biol Chem. 1998 Mar 27;273(13):7717-24 - PubMed
  87. J Control Release. 2016 Aug 10;235:259-267 - PubMed
  88. Pharmacol Res. 2019 Jan;139:395-411 - PubMed
  89. Br J Cancer. 2007 May 21;96(10):1520-5 - PubMed
  90. Mol Cancer Res. 2004 Dec;2(12):663-73 - PubMed
  91. Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7154-9 - PubMed
  92. Diabetes. 1981 Sep;30(9):757-61 - PubMed
  93. Biochim Biophys Acta. 2016 Dec;1858(12):3195-3204 - PubMed
  94. N Engl J Med. 2018 Jan 25;378(4):331-344 - PubMed
  95. J Cell Mol Med. 2008 Oct;12(5B):2003-14 - PubMed
  96. J Neurosci Res. 1989 Apr;22(4):464-72 - PubMed
  97. Mol Pharm. 2018 Nov 5;15(11):4854-4861 - PubMed
  98. Histochem J. 1989 Jan;21(1):47-51 - PubMed
  99. Genes (Basel). 2018 Nov 16;9(11): - PubMed
  100. J Cell Biol. 1987 Mar;104(3):585-93 - PubMed
  101. Angew Chem Int Ed Engl. 2011 Sep 26;50(40):9496-500 - PubMed
  102. Ann Oncol. 2007 Aug;18(8):1400-7 - PubMed
  103. J Neurooncol. 2020 Jun;148(2):245-258 - PubMed
  104. J Biol Chem. 1996 Nov 29;271(48):30942-9 - PubMed
  105. J Control Release. 2017 Aug 28;260:142-153 - PubMed
  106. N Engl J Med. 2015 Jul 2;373(1):48-59 - PubMed
  107. Nucl Med Biol. 2004 Feb;31(2):179-89 - PubMed
  108. Expert Opin Investig Drugs. 2008 Aug;17(8):1225-35 - PubMed
  109. Int J Cancer. 1999 Oct 29;83(3):326-34 - PubMed
  110. Cancer Biother Radiopharm. 2002 Dec;17(6):641-6 - PubMed
  111. Biomaterials. 2013 Dec;34(36):9134-41 - PubMed
  112. Sci Rep. 2020 Apr 2;10(1):5809 - PubMed
  113. J Clin Invest. 2003 Nov;112(10):1533-40 - PubMed
  114. Proc Natl Acad Sci U S A. 1984 Nov;81(22):7233-7 - PubMed
  115. Cancer Res. 2002 Feb 1;62(3):867-74 - PubMed
  116. Science. 1998 Jan 16;279(5349):377-80 - PubMed
  117. Mol Cancer Ther. 2012 Feb;11(2):308-16 - PubMed
  118. Mol Imaging Biol. 2015 Feb;17(1):76-86 - PubMed
  119. Methods Mol Biol. 2008;494:187-208 - PubMed
  120. Cancer Res. 2008 Sep 1;68(17):7210-8 - PubMed
  121. Circ Res. 2000 Oct 13;87(8):670-6 - PubMed
  122. Science. 1986 Jul 25;233(4762):467-70 - PubMed
  123. J Eur Acad Dermatol Venereol. 2014 Jan;28(1):108-11 - PubMed
  124. Blood. 1985 Oct;66(4):946-52 - PubMed
  125. Anal Biochem. 2010 Dec 15;407(2):237-40 - PubMed
  126. Blood. 1985 Sep;66(3):724-7 - PubMed
  127. J Pharm Sci. 1992 Aug;81(8):731-5 - PubMed
  128. EMBO J. 1994 Mar 15;13(6):1331-40 - PubMed
  129. Curr Opin Neurobiol. 1996 Oct;6(5):629-34 - PubMed
  130. Cancer Res. 2002 Nov 1;62(21):6146-51 - PubMed
  131. J Nucl Med. 2005 May;46(5):887-95 - PubMed
  132. Tumour Biol. 2016 Jul;37(7):9121-9 - PubMed
  133. J Biol Chem. 1997 Jun 20;272(25):16010-7 - PubMed
  134. Nucl Med Biol. 2006 Feb;33(2):227-37 - PubMed
  135. Sci Rep. 2017 Nov 7;7(1):14655 - PubMed
  136. J Mater Chem B. 2020 Mar 18;8(11):2296-2306 - PubMed
  137. Nature. 1979 Dec 6;282(5739):623-5 - PubMed
  138. J Neurochem. 1985 Nov;45(5):1642-8 - PubMed
  139. Adv Drug Deliv Rev. 2017 Feb;110-111:13-37 - PubMed
  140. Proc Natl Acad Sci U S A. 1985 Jul;82(13):4553-7 - PubMed
  141. Neuroscience. 2008 Aug 13;155(2):423-38 - PubMed
  142. Mol Pharm. 2014 Feb 3;11(2):486-95 - PubMed
  143. Mol Cell Endocrinol. 2008 May 14;286(1-2):230-7 - PubMed
  144. Int J Cancer. 1997 Mar 4;70(5):530-7 - PubMed
  145. Daru. 2017 May 2;25(1):13 - PubMed
  146. Nucleic Acids Res. 2014 Feb;42(3):1784-98 - PubMed
  147. J Clin Invest. 1986 Mar;77(3):997-1005 - PubMed
  148. Photochem Photobiol. 2009 Nov-Dec;85(6):1434-9 - PubMed
  149. Mol Imaging Biol. 2019 Apr;21(2):297-305 - PubMed
  150. Cells. 2019 May 10;8(5): - PubMed
  151. Oncol Lett. 2016 Nov;12(5):3241-3249 - PubMed
  152. Cancer Cell. 2016 Jul 11;30(1):18-25 - PubMed
  153. Neurosci Lett. 2001 Jun 22;306(1-2):1-4 - PubMed
  154. J Med Chem. 1989 Jan;32(1):174-9 - PubMed
  155. Cancer Res. 2006 Oct 15;66(20):10073-82 - PubMed
  156. Clin Cancer Res. 2006 Jan 1;12(1):175-82 - PubMed
  157. Pharm Res. 2009 Nov;26(11):2486-94 - PubMed
  158. J Biol Chem. 2002 Apr 5;277(14):11918-26 - PubMed
  159. Biomaterials. 2013 Jul;34(22):5628-39 - PubMed
  160. J Pharmacol Exp Ther. 2008 Mar;324(3):1064-72 - PubMed
  161. Transl Oncol. 2010 Apr;3(2):123-34 - PubMed
  162. Mol Pharm. 2018 Sep 4;15(9):3664-3671 - PubMed
  163. Clin Cancer Res. 2004 Nov 15;10(22):7621-8 - PubMed
  164. Nat Rev Cancer. 2008 Aug;8(8):604-17 - PubMed
  165. Mol Cancer Ther. 2014 Apr;13(4):996-1007 - PubMed
  166. Curr Opin Oncol. 2002 Jan;14(1):53-7 - PubMed
  167. Front Neurosci. 2019 Jan 11;12:1019 - PubMed
  168. Int J Pharm. 2016 Mar 16;500(1-2):128-35 - PubMed
  169. Oncotarget. 2016 Mar 22;7(12):15018-32 - PubMed
  170. Nat Rev Drug Discov. 2016 Feb;15(2):143 - PubMed
  171. Br J Dermatol. 2011 Feb;164(2):407-14 - PubMed
  172. Blood. 2008 Oct 1;112(7):2628-35 - PubMed
  173. Front Neuroendocrinol. 2013 Aug;34(3):228-52 - PubMed
  174. J Nucl Med. 2004 Jan;45(1):116-23 - PubMed
  175. Nat Med. 1999 Sep;5(9):1032-8 - PubMed
  176. Blood. 2011 Jan 20;117(3):920-7 - PubMed
  177. Mol Ther. 2008 Jan;16(1):115-123 - PubMed
  178. J Biol Chem. 2006 Nov 24;281(47):36466-76 - PubMed
  179. J Biol Chem. 1993 Sep 25;268(27):20205-10 - PubMed
  180. Peptides. 1992 Jul-Aug;13(4):681-9 - PubMed
  181. Science. 1973 Jan 5;179(4068):77-9 - PubMed
  182. J Clin Invest. 1963 Mar;42:314-26 - PubMed
  183. Pharmaceutics. 2020 Jan 17;12(1): - PubMed
  184. Bioconjug Chem. 2002 Jan-Feb;13(1):128-35 - PubMed
  185. Acta Oncol. 1991;30(4):463-8 - PubMed
  186. Sci Rep. 2017 Jan 11;7:39805 - PubMed
  187. Cancer. 2012 Nov 15;118(22):5601-7 - PubMed
  188. J Natl Cancer Inst. 1997 Sep 3;89(17):1260-70 - PubMed
  189. Oncol Rep. 2016 Jul;36(1):131-6 - PubMed
  190. Mol Oncol. 2018 Jan;12(1):3-20 - PubMed
  191. Cancer Cell. 2004 Sep;6(3):275-84 - PubMed
  192. J Pept Res. 2001 Jun;57(6):528-38 - PubMed
  193. J Biol Chem. 1999 Mar 12;274(11):7011-7 - PubMed
  194. Clin Cancer Res. 2013 Mar 15;19(6):1567-76 - PubMed
  195. Anticancer Res. 2014 Aug;34(8):3997-4003 - PubMed
  196. Life Sci. 1984 Mar 5;34(10):977-84 - PubMed
  197. J Biol Chem. 1998 Sep 11;273(37):23629-32 - PubMed
  198. Mol Imaging Biol. 2011 Apr;13(2):332-41 - PubMed
  199. Cancer Res. 2003 Aug 15;63(16):5046-53 - PubMed
  200. J Pharm Sci. 1985 Mar;74(3):237-40 - PubMed
  201. Cancer Res. 2001 Mar 1;61(5):1781-5 - PubMed
  202. Bioconjug Chem. 2008 Mar;19(3):634-42 - PubMed
  203. N Engl J Med. 1996 Jan 25;334(4):246-54 - PubMed
  204. J Control Release. 2016 Sep 28;238:212-220 - PubMed
  205. Oncogene. 2012 Aug 16;31(33):3754-63 - PubMed
  206. Science. 2002 Apr 5;296(5565):151-5 - PubMed
  207. Biochim Biophys Acta. 2008 May;1783(5):849-63 - PubMed
  208. Org Biomol Chem. 2010 Aug 21;8(16):3723-33 - PubMed
  209. J Biol Chem. 1994 Apr 8;269(14):10444-50 - PubMed
  210. Mol Pharm. 2020 May 4;17(5):1470-1481 - PubMed
  211. Endothelium. 2002;9(3):151-60 - PubMed
  212. JAMA Dermatol. 2015 Jan;151(1):42-50 - PubMed
  213. Eur J Cancer. 1994;30A(11):1682-7 - PubMed
  214. Mol Pharm. 2019 Apr 1;16(4):1694-1702 - PubMed
  215. Adv Drug Deliv Rev. 2017 Feb;110-111:3-12 - PubMed
  216. Recent Results Cancer Res. 2013;194:149-75 - PubMed
  217. Nat Biotechnol. 1997 Jun;15(6):542-6 - PubMed
  218. Biomaterials. 2014 May;35(14):4319-32 - PubMed
  219. FEBS Lett. 1991 Oct 7;291(1):50-4 - PubMed
  220. J Neurochem. 2008 Aug;106(4):1534-44 - PubMed
  221. Nat Rev Cancer. 2002 Mar;2(3):161-74 - PubMed
  222. J Cell Biol. 2003 Nov 24;163(4):871-8 - PubMed
  223. Amino Acids. 2017 Aug;49(8):1293-1308 - PubMed
  224. Cancer Res. 2013 Jan 15;73(2):804-12 - PubMed
  225. Cancer Res. 2004 Jan 15;64(2):565-71 - PubMed
  226. Bioconjug Chem. 2015 Aug 19;26(8):1850-61 - PubMed
  227. Brain Tumor Pathol. 1998;15(1):23-30 - PubMed
  228. J Pharm Biomed Anal. 2018 Apr 15;152:173-178 - PubMed
  229. Lancet Oncol. 2014 Dec;15(13):e584-e585 - PubMed
  230. Cell. 2000 Jan 7;100(1):57-70 - PubMed
  231. J Biol Chem. 1999 Aug 20;274(34):24425-30 - PubMed
  232. Sci Rep. 2019 Sep 24;9(1):13802 - PubMed
  233. Int J Radiat Biol. 2020 Nov;96(11):1443-1451 - PubMed
  234. Nat Biotechnol. 2003 Jul;21(7):778-84 - PubMed
  235. J Nucl Med. 2001 Dec;42(12):1847-55 - PubMed
  236. Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9381-6 - PubMed
  237. Trends Immunol. 2019 Apr;40(4):310-327 - PubMed
  238. Cancer Cell. 2003 Aug;4(2):133-46 - PubMed
  239. Metabolism. 1987 Sep;36(9):892-5 - PubMed
  240. Sci Transl Med. 2018 Nov 7;10(466): - PubMed
  241. Cell. 1985 Sep;42(2):439-48 - PubMed
  242. J Neurochem. 1985 Jun;44(6):1771-8 - PubMed
  243. Cancer Cell. 2009 Dec 8;16(6):510-20 - PubMed
  244. Adv Drug Deliv Rev. 2005 Feb 28;57(4):559-77 - PubMed
  245. Cell. 1989 Sep 8;58(5):933-43 - PubMed
  246. Nat Med. 2002 Jul;8(7):751-5 - PubMed
  247. Pharmacol Ther. 2015 Oct;154:78-86 - PubMed
  248. Mol Cancer Ther. 2002 Sep;1(11):901-11 - PubMed
  249. Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16157-62 - PubMed
  250. Lancet Oncol. 2014 Sep;15(10):1100-8 - PubMed
  251. Org Biomol Chem. 2014 Jun 21;12(23):3877-86 - PubMed
  252. PLoS Comput Biol. 2013 Oct;9(10):e1003277 - PubMed
  253. Mol Pharm. 2009 Jan-Feb;6(1):231-45 - PubMed
  254. Nucl Med Biol. 2015 Dec;42(12):939-44 - PubMed
  255. J Pept Sci. 2016 May;22(5):360-7 - PubMed
  256. Semin Nucl Med. 2002 Apr;32(2):92-6 - PubMed
  257. Appl Radiat Isot. 2019 Jun;148:168-177 - PubMed
  258. Cancer Treat Rev. 2019 Nov;80:101896 - PubMed
  259. J Biol Chem. 1990 Oct 15;265(29):18035-40 - PubMed
  260. J Photochem Photobiol B. 2016 Nov;164:226-235 - PubMed
  261. Cancers (Basel). 2020 Jul 08;12(7): - PubMed
  262. Oncogene. 2018 Mar;37(12):1561-1575 - PubMed
  263. Biologicals. 2001 Sep-Dec;29(3-4):293-8 - PubMed
  264. Acta Endocrinol (Copenh). 1986 Apr;111(4):433-9 - PubMed
  265. J Control Release. 2000 Feb 3;63(3):261-73 - PubMed
  266. Nature. 1984 May 3-9;309(5963):30-3 - PubMed
  267. J Control Release. 2014 Feb 10;175:48-53 - PubMed
  268. Lancet Oncol. 2014 Sep;15(10):1044-5 - PubMed
  269. Int J Cancer. 1988 Feb 15;41(2):248-55 - PubMed
  270. Anal Biochem. 2008 Feb 1;373(1):88-98 - PubMed
  271. Proc Natl Acad Sci U S A. 1986 Dec;83(23):8819-23 - PubMed
  272. Nucleic Acids Res. 2012 Jan;40(Database issue):D271-7 - PubMed
  273. Lancet Oncol. 2014 Dec;15(13):e585-e586 - PubMed
  274. Curr Med Chem. 2010;17(13):1255-99 - PubMed
  275. Cancer Res. 2003 Nov 1;63(21):7400-9 - PubMed
  276. Cell Mol Life Sci. 2005 Oct;62(19-20):2325-38 - PubMed
  277. Mol Ther. 2009 May;17(5):837-43 - PubMed
  278. Important Adv Oncol. 1996;:69-87 - PubMed
  279. Int J Mol Sci. 2014 Dec 24;16(1):148-58 - PubMed
  280. Clin Exp Dermatol. 2014 Mar;39(2):168-75 - PubMed
  281. Acta Biomater. 2017 Dec;64:323-333 - PubMed
  282. Nucl Med Biol. 2020 Nov - Dec;90-91:84-92 - PubMed
  283. Hum Gene Ther. 2004 Apr;15(4):373-82 - PubMed
  284. Nature. 1984 Nov 8-14;312(5990):162-3 - PubMed
  285. J Med Chem. 1996 Aug 2;39(16):3107-13 - PubMed
  286. Peptides. 1994;15(7):1297-302 - PubMed
  287. Toxins (Basel). 2015 Apr 01;7(4):1126-50 - PubMed
  288. Methods Mol Biol. 2013;1047:191-9 - PubMed
  289. Nucl Med Biol. 2010 Apr;37(3):365-70 - PubMed
  290. Curr Radiopharm. 2012 Jan;5(1):15-8 - PubMed
  291. J Med Chem. 1999 Aug 12;42(16):3033-40 - PubMed
  292. Skin Pharmacol Physiol. 2015;28(2):103-13 - PubMed
  293. Mol Med Rep. 2017 Jan;15(1):323-330 - PubMed
  294. Int J Mol Med. 2004 Oct;14(4):529-35 - PubMed
  295. Exp Cell Res. 1989 Apr;181(2):463-74 - PubMed
  296. J Neurochem. 2002 Nov;83(4):924-33 - PubMed
  297. Biomed Res Int. 2019 Jan 10;2019:8534761 - PubMed
  298. Adv Drug Deliv Rev. 2013 Jan;65(1):36-48 - PubMed
  299. Mol Cancer Ther. 2008 May;7(5):1044-53 - PubMed
  300. Int J Biol Sci. 2019 Jun 2;15(7):1452-1459 - PubMed
  301. Biochemistry. 1991 Jul 30;30(30):7369-72 - PubMed
  302. Nature. 1978 Apr 27;272(5656):827-9 - PubMed

Publication Types

Grant support